Background: The initial presentation of malignant hyperthermia (MH) may begin in the postoperative period. However, the maximal latency period between the end of anesthesia care and the onset of postoperative MH is unknown.
Kim, Yung Ly +4 more
core +1 more source
Unmasking malignant hyperthermia: a rapid response to a hypermetabolic crisis: case report
IntroductionMalignant Hyperthermia is a rare, life-threatening pharmacogenetic disorder that can occur after exposure to triggering anesthetic agents, including volatile anesthetics and succinylcholine.Case presentationAn 18-year-old male with multiple ...
En Chang +5 more
doaj +1 more source
Malignant hyperthermia in a patient with sickle cell anemia
A sixteen-year-old male with sickle cell anemia and congenital strabismus developed malignant hyperthermia a few minutes after the administration of succinylcholine, used as the general anesthetic for corrective eye surgery.
A Gürgey, C Altay, S Ozgen
doaj
Lightning Strikes Twice in the Same Place: Mitochondrial Myopathy and Malignant Hyperthermia-A Case Report. [PDF]
de Melo RSES +9 more
europepmc +1 more source
Malignant Hyperthermia in Sweden: Clinical Presentations and Genetic Findings. [PDF]
Hellblom A, Soller M, Samuelsson C.
europepmc +1 more source
Malignant Hyperthermia in the Ambulatory Surgical Unit
provided education for malignant hyperthermia in an ambulatory surgery ...
Cullinan, Bridget
core
Delayed-Onset Malignant Hyperthermia With Disseminated Intravascular Coagulation Following Successful Prior Anesthetic Use: A Case Report. [PDF]
Buleza N, Ramadan L.
europepmc +1 more source
Use of extracorporeal cardiopulmonary resuscitation in malignant hyperthermia-induced sudden cardiac arrest - A case study. [PDF]
Woźnica-Niesobska E +3 more
europepmc +1 more source
Perioperative Management of Coexisting Mast Cell Activation Syndrome and Malignant Hyperthermia Susceptibility: A Case Report and Novel Approach to Local Analgesia. [PDF]
Gearing PF +4 more
europepmc +1 more source
Estimating the Prevalence of Malignant Hyperthermia Susceptibility Based on Causative <i>RYR1</i> and <i>CACNA1S</i> Variants. [PDF]
Efremova E +12 more
europepmc +1 more source

